Evidence map›Paper›PMID 38450361›Full record

ArticleHospital pharmacy2024

Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario.

Andrea Zovi, Ruggero Lasala, Francesco Ferrara, Roberto Langella, Antonio Vitiello, Michela Sabbatucci, Umberto Maria Musazzi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hospital pharmacy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Andrea ZoviUniversity of Camerino, Camerino, Italy.ORCID https://orcid.org/0000-0002-6528-2171
Ruggero LasalaLocal Health Unit of Bari, Bari, Italy.
Francesco FerraraAsl Napoli 3 Sud, Nola, Naples, Italy.
Roberto LangellaAgency for Health Protection of the Metropolitan Area of Milan, Milan, Italy.
Antonio VitielloMinistry of Health, Rome, Italy.
Michela SabbatucciMinistry of Health, Rome, Italy.
Umberto Maria MusazziUniversity of Milan, Milan, Italy.
Ministero della Salute · ITMetropolitana Milanese (Italy) · ITUniversità di Camerino · ITUniversity of Bari Aldo Moro · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-CGRP mAbscosteffectivenesseptinezumaberenumabfremanezumabgalcanezumabmigrainesaving

Identifiers

PMID38450361
PMCPMC10913879
OpenAlexW4389000077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.